OCUL OCULAR THERAPEUTIX, INC

NEUTRAL Impact: 3/10 Insider Cluster (4 insiders)
Horizon days Filed May 28, 2026 Processed 9d 5h ago
Insider cluster: 4 insiders, $0.2M total

Price Chart

Loading chart...

Executive Summary

Four OCUL insiders, including the Chief Scientific Officer and Chief Development Officer, conducted open-market sales of 28,999 shares for $238K, all at $8.20 on May 26, 2026. The cluster is small in magnitude (0.01% of the $1.9B market cap), concentrated on a single date, and likely driven by a shared trading-window opening or tax-planning event — not material negative information. The $0 gift of 394,696 shares by Dugel Pravin has no economic impact. Net direction is selling but routine for a mid-cap pharma company.

Key Financial Metrics

Direction
selling
Total Value
$237.8K
Insiders
4

Actionable Insight

This is a low-signal insider cluster. The identical price ($8.20) and single-day concentration across multiple executives suggest a 10b5-1 plan or window-opening event rather than opportunistic selling. Lab-lead (CSO, CDO) participation also points to vesting-driven sales, not fundamental concern. Ignore for trading. Monitor the 30-day pipeline for any material clinical news that might have motivated the gift.

Key Facts

  • Four C-suite/executive insiders sold 28,999 shares in open-market transactions on May 26, 2026, all at $8.20/share.
  • Total cluster sales value: $237,792 — just 0.013% of OCUL's $1.9B market cap (well below the 0.1% triviality threshold).
  • Dugel Pravin additionally gifted 394,696 shares on May 28 at $0 (non-economic event).
  • No purchases occurred in the cluster window; the net direction is selling.
  • The sales are small in dollar terms and cluster on a single date, consistent with a routine blackout-window opening or end-of-month 10b5-1 plan execution.

Financial Impact

Total insider sales of $238K represent 0.013% of market cap — economically trivial.

insider_ownershipcash_balance

Risk Factors

  • Historical performance on OCUL filing reports shows a 38% win rate and -6.91% average T+20 return — prior high-signal reads on this name have not been rewarded.
  • A 394K-share gift by Dugel Pravin could precede share transfers to a trust or family member — no immediate price impact, but may reduce beneficial-owner alignment.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
94% bullish (18 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-OCUL-1779999078058
9 reports for OCUL
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for OCUL — sortable, filterable
Type Now
Jun 4, 2026
2d ago
Press Release
BULLISH ★ 7/10
$8.80 $8.25▼ −6.25%▼ −3.65%$8.25 (−6.25%)
May 28, 2026
9d ago
Insider Cluster
NEUTRAL ★ 3/10
awaiting T+1
May 5, 2026
4w ago
8-K
NEUTRAL ★ 5/10
$9.71 $9.71· 0.00%▼ −1.38%$8.25 (−15.04%)
May 5, 2026
4w ago
Press Release
MIXED ★ 6/10
$9.71 $9.71· 0.00%▼ −1.38%$8.25 (−15.04%)
Apr 30, 2026
5w ago
DEFA14A
NEUTRAL ★ 3/10
awaiting T+1
Apr 13, 2026
7w ago
Press Release
BULLISH ★ 8/10
$8.86 $8.76▼ −1.13%▼ −2.34%$8.25 (−6.88%)
Apr 1, 2026
9w ago
Press Release
NEUTRAL ★ 3/10
$8.33 $8.49▲ +1.92%▲ +1.84%$8.25 (−0.96%)
Feb 20, 2026
15w ago
Insider Cluster
MIXED ★ 5/10
$7.78 $8.41▲ +8.10%▲ +9.11%$8.25 (+6.04%)
Feb 20, 2026
15w ago
Insider Cluster
MIXED ★ 6/10
$7.78 $8.41▲ +8.10%▲ +9.11%$8.25 (+6.04%)
Showing 9 of 9

US Market Status

Market Closed — Opens Mon (12h 3m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access